Comme chaque année, la société fournit les montants des rémunérations des dirigeants mais très peu d'information sur la politique de rémunération. De plus, elle ne soumet pas de résolutions permettant aux actionnaires de se prononcer sur ce sujet. Par conséquent, notre réserve s'exprimera par une recommandation négative sur la demande de quitus en faveur des administrateurs qui est une résolution obligatoire au Luxembourg (résolution 7).
Deux renouvellements d’administrateurs sont soumis au vote. Nous soutiendrons la candidature de Patrizia Luchetta ainsi que de Fereshteh Pouchantchi, toutes deux libres de conflits d’intérêt (résolutions 9 et 10).
Eurofins Scientific is an international life sciences company operating in food & pharmaceutical products testings. Co. provides analytical testing services to clients from various industries including pharmaceutical, food, and environmental sectors. Co. offers analytical methods for evaluating the authenticity, origin, safety, identity, composition, and purity of biological substances & products. Co. verifies authenticity of products analyzed to detect dangerous components (pathogens, prions, pesticides, asbestos, mycotoxins, dioxins, toxic substances, etc.). Co. operates in Benelux, France, Germany, North America, Scandinavia, British Isles (U.K. & Republic of Ireland), & other countries.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Announcement: Moody's corrects treatment for Eurofins' hybrids, ratings are unchanged. Global Credit Research- 08 Sep 2020. Frankfurt am Main, September 08, 2020-- Moody's Investors Service corrects the basket classification and equity credit percentages of two out of three outstanding hybrid instruments.
EUROFINS SCIENTIFIC - BUY | EUR575 A win/win position whatever the scenario Eurofins is not a diagnostic companyâ€¦ An extensive offer allowing to propose solutions to help fight Covid-19 A crisis that appears to be an opportunity A win/win position whatever the scenario
In general, Unilever plc ("Unilever") is in compliance with the UK regulations relating to the organisation and procedures of the Extraordinary General Meeting. Under ITEM 1 approval is sought for a unification of Unilever under a single parent company: Unilever plc (i.e. Unilever NV will cease to exist). First of all, ECGS strongly endorses the strategic rationale of the (proposed) unification. It acknowledges the increased strategic flexibility and enhanced corporate governance in terms share structure and applicable regulators. Despite that the unification offers some corporate governanc...
Items 3 and 4: Remuneration report and policy Our concerns regarding the excessive short-term incentive overwhelm the positive features of the Hargreaves Lansdown's remuneration such as acceptable quantum and the payout adequately aligned with performance. We strongly disagree with any remuneration weighted more towards rewarding short-term performance and any LTI awards without performance conditions. Item 21: Amend the Hargreaves Lansdown Sustained Performance Plan 2017 We do not consider the proposed plan conditions satisfactory: ECGS strongly believes that the executive LTI should be su...
In general, Colruyt is compliant with the Belgian regulations relating to the organisation and procedures of an Extraordinary General Meeting. Under ITEM II.3, the board of directors seeks authorisation to increase the Company's share capital to issue shares to its employees. As a matter of principle, ECGS generally favours employee stock ownership plans since such plans help to align the interests of employees with those of their companies. However, since the authority requested is not conform to its guidelines, ECGS recommends to vote OPPOSE. In ECGS' view, ITEMS II.4 - II.8 are enabling r...
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.